INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY

Bibliographic Details
Main Authors:	Sibley, W, Ebers, G, Panitch, H, Reder, A, Vandennoort, S
Format:	Journal article
Published:	1994

Similar Items

Treatment of multiple sclerosis with interferon beta-1b - Reply
by: Sibley, W, et al.
Published: (1997)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
by: Petkau, A, et al.
Published: (2004)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferon beta treatment of multiple sclerosis.
by: Markovitz, D
Published: (1994)

MULTIPLE-SCLEROSIS IN TWINS - REPLY
by: Ebers, G
Published: (1987)

Treatment of multiple sclerosis with interferon beta-1 b.
by: Abdul-Ahad, A, et al.
Published: (1997)

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS
by: Mohamed Rayen Ganouni, et al.
Published: (2023-10-01)

Systemic interferon alfa in multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1989)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
by: Petkau, A, et al.
Published: (2004)

PAIN IN MULTIPLE-SCLEROSIS - REPLY
by: Moulin, D, et al.
Published: (1989)

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis
by: Ebers, G, et al.
Published: (2005)

INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
by: Duquette, P, et al.
Published: (1995)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
by: Ebers, G, et al.
Published: (2009)

MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS Reply
by: Ebers, G, et al.
Published: (2009)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
by: Alexandre Xavier, et al.
Published: (2023-05-01)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)

OLIGOCLONAL BANDS IN MULTIPLE-SCLEROSIS - CLINICAL-PATHOLOGICAL CORRELATION - REPLY
by: Farrell, M, et al.
Published: (1986)

OLIGOCLONAL BANDS IN MULTIPLE-SCLEROSIS - AN INDEX OF DISEASE-ACTIVITY - REPLY
by: Ebers, G, et al.
Published: (1985)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
by: Ebers, G, et al.
Published: (1998)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
by: Sørensen, P, et al.
Published: (2010)

Interferon-beta injection site reactions in patients with multiple sclerosis
by: Martina Maurelli, et al.
Published: (2018-11-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01)

A cost-utility analysis of interferon beta for multiple sclerosis.
by: Parkin, et al.
Published: (1998-01-01)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
by: Parry, A, et al.
Published: (2003)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
by: Parry, A, et al.
Published: (2002)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY
by: Noseworthy, J, et al.
Published: (1990)

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years
by: Duquette, P, et al.
Published: (1996)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
by: Lampasona, V, et al.
Published: (2003)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01)

Treatment of multiple sclerosis.
by: Ebers, G
Published: (1994)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
by: Filippini, G, et al.
Published: (2003)

TCR beta polymorphisms and multiple sclerosis.
by: Dyment, D, et al.
Published: (2004)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
by: Naeim Ehtesham, et al.
Published: (2016-11-01)

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
by: Miraç Ayşen Ünsal
Published: (2019-03-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis (vol 352, pg 1498, 1998)
by: Ebers, G, et al.
Published: (1999)

The final results of the interferon beta-1b 16-year long-term follow-up study
by: Ebers, G, et al.
Published: (2006)

Problems of interchangeability of systemic interferons for treatment of multiple sclerosis
by: I. I. Snegireva, et al.
Published: (2018-02-01)